Proteoglycan-induced arthritis and recombinant human proteoglycan aggrecan G1 domain-induced arthritis in BALB/c mice resembling two subtypes of rheumatoid arthritis

Arthritis and Rheumatism

Volumn 63, Issue 5, 2011, Pages 1312-1321

  Glant, Tibor T ^a,e   Radacs, Marianna ^a   Nagyeri, Gyorgy ^b   Olasz, Katalin ^c   Laszlo, Anna ^d   Boldizsar, Ferenc ^c   Hegyi, Akos ^a   Finnegan, Alison ^a   Mikecz, Katalin ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF SZEGED   (Hungary)

^c UNIVERSITY OF PÉCS   (Hungary)

^d Calculus Ltd   (Hungary)

^e Cohn Research Building ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGGRECAN; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; IMMUNOGLOBULIN G; PROTEOGLYCAN; RHEUMATOID FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRITIS; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; DISEASE COURSE; DISEASE MODEL; DISEASE SEVERITY; HISTOPATHOLOGY; IMMUNE RESPONSE; IMMUNIZATION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEOGLYCAN INDUCED ARTHRITIS; RECOMBINANT HUMAN PROTEOGLYCAN G1 DOMAIN INDUCED ARTHRITIS; RHEUMATOID ARTHRITIS; T LYMPHOCYTE; TH1 CELL; TH17 CELL;

AGGRECANS; ANALYSIS OF VARIANCE; ANIMALS; ARTHRITIS, EXPERIMENTAL; ARTHRITIS, RHEUMATOID; CARTILAGE, ARTICULAR; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNIZATION; INTERLEUKINS; MICE; MICE, INBRED BALB C; PROTEOGLYCANS; RHEUMATOID FACTOR; T-LYMPHOCYTES;

EID: 79955569160     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.30261     Document Type: Article

References (48)

1. Gregersen PK,. Genetics of rheumatoid arthritis: confronting complexity. Arthritis Res 1999; 1: 37-44. (Pubitemid 32223665)
2. Bevaart L, Vervoordeldonk MJ, Tak PP,. Evaluation of therapeutic targets in animal models of arthritis: how does it relate to rheumatoid arthritis? [review]. Arthritis Rheum 2010; 62: 2192-205.
3. Glant TT, Mikecz K, Arzoumanian A, Poole AR,. Proteoglycan-induced arthritis in BALB/c mice: clinical features and histopathology. Arthritis Rheum 1987; 30: 201-12. (Pubitemid 17060776)
4. Mikecz K, Glant TT, Poole AR,. Immunity to cartilage proteoglycans in BALB/c mice with progressive polyarthritis and ankylosing spondylitis induced by injection of human cartilage proteoglycan. Arthritis Rheum 1987; 30: 306-18. (Pubitemid 17098583)
5. Glant TT, Finnegan A, Mikecz K,. Proteoglycan-induced arthritis: immune regulation, cellular mechanisms and genetics. Crit Rev Immunol 2003; 23: 199-250. (Pubitemid 37204432)
6. Etzel CJ, Chen WV, Shepard N, Jawaheer D, Cornelis F, Seldin MF, et al. Genome-wide meta-analysis for rheumatoid arthritis. Hum Genet 2006; 119: 634-41. (Pubitemid 43805840)
7. Choi SJ, Rho YH, Ji JD, Song GG, Lee YH,. Genome scan meta-analysis of rheumatoid arthritis. Rheumatology (Oxford) 2006; 45: 166-70. (Pubitemid 43160077)
8. Zhang Y, Guerassimov A, Leroux JY, Cartman A, Webber C, Lalic R, et al. Induction of arthritis in BALB/c mice by cartilage link protein: involvement of distinct regions recognized by T and B lymphocytes. Am J Pathol 1998; 153: 1283-91. (Pubitemid 28465852)
9. Verheijden GF, Rijnders AW, Bos E, Coenen-de Roo CJ, van Staveren CJ, Miltenburg AM, et al. Human cartilage glycoprotein-39 as a candidate autoantigen in rheumatoid arthritis. Arthritis Rheum 1997; 40: 1115-25. (Pubitemid 27242299)
10. Adarichev VA, Valdez JC, Bardos T, Finnegan A, Mikecz K, Glant TT,. Combined autoimmune models of arthritis reveal shared and independent qualitative (binary) and quantitative trait loci. J Immunol 2003; 170: 2283-92. (Pubitemid 36245613)
11. Glant TT, Mikecz K,. Proteoglycan aggrecan-induced arthritis: a murine autoimmune model of rheumatoid arthritis. Methods Mol Med 2004; 102: 313-38.
12. Ohmura K, Johnsen A, Ortiz-Lopez A, Desany P, Roy M, Besse W, et al. Variation in IL-1β gene expression is a major determinant of genetic differences in arthritis aggressivity in mice. Proc Natl Acad Sci U S A 2005; 102: 12489-94. (Pubitemid 41266386)
13. Uysal H, Nandakumar KS, Kessel C, Haag S, Carlsen S, Burkhardt H, et al. Antibodies to citrullinated proteins: molecular interactions and arthritogenicity. Immunol Rev 2010; 233: 9-33.
14. Koga T, Kakimoto K, Hirofuji T, Kotani S, Ohkuni H, Watanabe K, et al. Acute joint inflammation in mice after systemic injection of the cell wall, its peptidoglycan, and chemically defined peptidoglycan subunits from various bacteria. Infect Immun 1985; 50: 27-34. (Pubitemid 15239183)
15. Horai R, Saijo S, Tanioka H, Nakae S, Sudo K, Okahara A, et al. Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice. J Exp Med 2000; 191: 313-20. (Pubitemid 30060920)
16. Sakaguchi N, Takahashi T, Hata H, Nomura T, Tagami T, Yamazaki S, et al. Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice. Nature 2003; 426: 454-60. (Pubitemid 37490133)
17. Glant TT, Cs-Szabo G, Nagase H, Jacobs JJ, Mikecz K,. Progressive polyarthritis induced in BALB/c mice by aggrecan from normal and osteoarthritic human cartilage. Arthritis Rheum 1998; 41: 1007-18. (Pubitemid 28265403)
18. Hanyecz A, Berlo SE, Szanto S, Broeren CP, Mikecz K, Glant TT,. Achievement of a synergistic adjuvant effect on arthritis induction by activation of innate immunity and forcing the immune response toward the Th1 phenotype. Arthritis Rheum 2004; 50: 1665-76. (Pubitemid 38608090)
19. Glant TT, Buzas EI, Finnegan A, Negroiu G, Cs-Szabo G, Mikecz K,. Critical role of glycosaminoglycan side chains of cartilage proteoglycan (aggrecan) in antigen recognition and presentation. J Immunol 1998; 160: 3812-9. (Pubitemid 28176085)
20. Buzas E, Vegvari A, Murad YM, Finnegan A, Mikecz K, Glant TT,. T-cell recognition of differentially tolerated epitopes of cartilage proteoglycan aggrecan in arthritis. Cell Immunol 2005; 235: 98-108. (Pubitemid 41597473)
21. Szanto S, Bardos T, Szabo Z, David CS, Buzas E, Mikecz K, et al. Induction of arthritis in HLA-DR4-humanized and HLA-DQ8-humanized mice by human cartilage proteoglycan aggrecan but only in the presence of an appropriate (non-MHC) genetic background. Arthritis Rheum 2004; 50: 1984-95. (Pubitemid 38725111)
22. Zhang Y, Guerassimov A, Leroux JY, Cartman A, Webber C, Lalic R, et al. Arthritis induced by proteoglycan aggrecan G1 domain in BALB/c mice: evidence for T cell involvement and the immunosuppressive influence of keratan sulfate on recognition of T and B cell epitopes. J Clin Invest 1998; 101: 1678-86. (Pubitemid 28198497)
23. Murad YM, Szabo Z, Ludanyi K, Glant TT,. Molecular manipulation with the arthritogenic epitopes of the G1 domain of human cartilage proteoglycan aggrecan. Clin Exp Immunol 2005; 142: 303-11. (Pubitemid 41565246)
24. Glant TT, Bardos T, Vermes C, Chandrasekaran R, Valdez JC, Otto JM, et al. Variations in susceptibility to proteoglycan-induced arthritis and spondylitis among C3H substrains of mice: evidence of genetically acquired resistance to autoimmune disease. Arthritis Rheum 2001; 44: 682-92. (Pubitemid 32234628)
25. Szabo Z, Szanto S, Vegvari A, Szekanecz Z, Mikecz K, Glant TT,. Genetic control of experimental spondylarthropathy. Arthritis Rheum 2005; 52: 2452-60. (Pubitemid 41117432)
26. Finnegan A, Mikecz K, Tao P, Glant TT,. Proteoglycan (aggrecan)-induced arthritis in BALB/c mice is a Th1-type disease regulated by Th2 cytokines. J Immunol 1999; 163: 5383-90.
27. Hollo K, Glant TT, Garzo M, Finnegan A, Mikecz K, Buzas EI,. Complex pattern of Th1 and Th2 activation with a preferential increase of autoreactive Th1 cells in BALB/c mice with proteoglycan (aggrecan)-induced arthritis. Clin Exp Immunol 2000; 120: 167-73. (Pubitemid 30176915)
28. Doodes PD, Cao Y, Hamel KM, Wang Y, Farkas B, Iwakura Y, et al. Development of proteoglycan-induced arthritis is independent of IL-17. J Immunol 2008; 181: 329-37.
29. Doodes PD, Cao Y, Hamel KM, Wang Y, Rodeghero RL, Mikecz K, et al. IFN-γ regulates the requirement for IL-17 in proteoglycan-induced arthritis. J Immunol 2010; 184: 1552-9.
30. Boldizsar F, Tarjanyi O, Nemeth P, Mikecz K, Glant TT,. Th1/Th17 polarization and acquisition of an arthritogenic phenotype in arthritis-susceptible BALB/c, but not in MHC-matched, arthritis-resistant DBA/2 mice. Int Immunol 2009; 21: 511-22.
31. Ahlqvist E, Hultqvist M, Holmdahl R,. The value of animal models in predicting genetic susceptibility to complex diseases such as rheumatoid arthritis. Arthritis Res Ther 2009; 11: 226-35.
32. Cai C, La Cava A,. Mimicking self-antigens with synthetic peptides in systemic autoimmune rheumatic diseases. Curr Clin Pharmacol 2009; 4: 142-7.
33. Van den Berg WB,. Lessons from animal models of arthritis over the past decade. Arthritis Res Ther 2009; 11: 250.
34. Taneja V, Taneja N, Paisansinsup T, Behrens M, Griffiths M, Luthra H, et al. CD4 and CD8 T cells in susceptibility/protection to collagen-induced arthritis in HLA-DQ8-transgenic mice: implications for rheumatoid arthritis. J Immunol 2002; 168: 5867-75. (Pubitemid 34556175)
35. Taneja V, Behrens M, Mangalam A, Griffiths MM, Luthra HS, David CS,. New humanized HLA-DR4-transgenic mice that mimic the sex bias of rheumatoid arthritis. Arthritis Rheum 2007; 56: 69-78. (Pubitemid 46110635)
36. Taneja V, Behrens M, Basal E, Sparks J, Griffiths MM, Luthra H, et al. Delineating the role of the HLA-DR4 "shared epitope" in susceptibility versus resistance to develop arthritis. J Immunol 2008; 181: 2869-77.
37. Kidd BA, Ho PP, Sharpe O, Zhao X, Tomooka BH, Kanter JL, et al. Epitope spreading to citrullinated antigens in mouse models of autoimmune arthritis and demyelination. Arthritis Res Ther 2008; 10: R119.
38. Jasin HE,. Autoantibody specificities of immune complexes sequestered in articular cartilage of patients with rheumatoid arthritis and osteoarthritis. Arthritis Rheum 1985; 28: 241-8. (Pubitemid 15133567)
39. Monach PA, Hueber W, Kessler B, Tomooka BH, Benbarak M, Simmons BP, et al. A broad screen for targets of immune complexes decorating arthritic joints highlights deposition of nucleosomes in rheumatoid arthritis. Proc Natl Acad Sci U S A 2009; 106: 15867-72.
40. Stuart JM, Dixon FJ,. Serum transfer of collagen-induced arthritis in mice. J Exp Med 1983; 158: 378-92. (Pubitemid 13049395)
41. Korganow AS, Ji H, Mangialaio S, Duchatelle V, Pelanda R, Martin T, et al. From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins. Immunity 1999; 10: 451-61. (Pubitemid 29205481)
42. Kuhn KA, Kulik L, Tomooka B, Braschler KJ, Arend WP, Robinson WH, et al. Antibodies against citrullinated proteins enhance tissue injury in experimental autoimmune arthritis. J Clin Invest 2006; 116: 961-73.
43. Nielen MM, van Schaardenburg D, Reesink HW, Twisk JW, van de Stadt RJ, van der Horst-Bruinsma IE, et al. Simultaneous development of acute phase response and autoantibodies in preclinical rheumatoid arthritis. Ann Rheum Dis 2006; 65: 535-7.
44. Goldbach-Mansky R, Lee J, McCoy A, Hoxworth J, Yarboro C, Smolen JS, et al. Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset. Arthritis Res 2000; 2: 236-43. (Pubitemid 32223739)
45. Andersson AK, Li C, Brennan FM,. Recent developments in the immunobiology of rheumatoid arthritis. Arthritis Res Ther 2008; 10: 204-12.
46. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO III, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 2010; 69: 1580-8.
47. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO III, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010; 62: 2569-81.
48. Cs-Szabo G, Roughley PJ, Plaas AH, Glant TT,. Large and small proteoglycans of osteoarthritic and rheumatoid articular cartilage. Arthritis Rheum 1995; 38: 660-8.